A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of...
from NDTV News - World-news https://ift.tt/3DnkFWy
Nepal Entertainment Buddy.
